← Open Payments lookup

DEBRA HAIN: Open Payments

NPI 1932139482 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,259 in 16 payments from 7 companies in 2025. Trend: 2023 $4,869 · 2024 $3,621 · 2025 $7,259

Consulting: $5,737Food & beverage: $1,208Travel & lodging: $314
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.8$6,423
Ardelyx, Inc.2$221
Amgen Inc.2$215
Apellis Pharmaceuticals, Inc.1$139
Novo Nordisk Inc1$120
CorMedix Inc.1$107
Novartis Pharmaceuticals Corporation1$35

Products named: TARPEYO, KRYSTEXXA, XPHOZAH 30 MG, Rivfloza, DEFENCATH, IBSRELA, Fabhalta.

Industry payments across UT — which companies pay providers there.